Zullig, Leah L.
Drake, Connor
Shahsahebi, Mohammad
Avecilla, Renee A. V.
Whitney, Colette
Mills, Coleman
Oeffinger, Kevin C.
Funding for this research was provided by:
National Cancer Institute (CA249568)
Article History
Received: 9 March 2022
Accepted: 13 April 2022
First Online: 17 May 2022
Declarations
:
: This is a systematic literature review. Ethics approval was not required.
: Not applicable.
: Not applicable.
: Dr. Zullig reports research funding from Proteus Digital Health and the PhRMA Foundation, as well as consulting from Novartis — none related to the current work. All other authors have no relevant financial or non-financial interests to disclose.